To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.

NCT05187715 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: Simvastatin 40mg
OTHER: Placebo
OTHER: Standard medical Treatment

Sponsor

Institute of Liver and Biliary Sciences, India